https://www.sanofi.com/en
Sanofi is a leading company in innovative healthcare solutions, with a focus on five therapeutic areas and a pipeline of 77 compounds in clinical development. Learn more about Sanofi's latest news, science, partnerships, and career opportunities.
https://www.sanofi.us/en
Sanofi is a global pharmaceutical company that develops and provides treatments for various diseases and conditions. Learn about its latest news, initiatives, and career opportunities in the US.
https://www.sanofi.us/en/our-company
Sanofi is a leading global pharmaceutical company with a purpose to chase the miracles of science and improve people's lives. Learn about its strategy, social impact, legacy, and products in the U.S.
https://www.sonifi.com/
SONIFI offers reliable and effective guest-facing technology for all major brands and independent properties. Learn how SONIFI can enhance your guest experience with in-room solutions, interactive platforms and more.
https://www.sanofi.us/en/your-health/products
Sanofi is a global healthcare leader that offers prescription medicines, vaccines, generics, and consumer health products. Learn more about their products and resources for U.S. residents.
https://www.sonifihealth.com/
SONIFI Health offers a platform of interactive TV, digital whiteboard, digital door sign, mobile, and digital signage solutions for healthcare organizations. Learn how SONIFI Health can help you create better care experiences with a hospitality mindset.
https://www.sonifi.com/interactive-solutions/
Scalable to fit your needs & brand experience. SONIFI is a brand-approved interactive TV supplier for: Marriott International. Hyatt Hotels. Wyndham Hotels. Choice Hotels. Unique properties deserve unique in-room technology experiences—see what SONIFI's interactive TV can do in: Independent & boutique hotels. Casino & gaming hotels.
https://www.linkedin.com/company/sanofi
Sanofi is an innovative company that provides treatments and vaccines for various diseases and conditions. Follow its LinkedIn page to see its latest news, updates, and achievements in the pharmaceutical industry.
https://en.wikipedia.org/wiki/Sanofi
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France.The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo.In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers.It changed its name back to Sanofi in May 2011.
https://www.news.sanofi.us/2021-06-17-Newly-licensed-US-manufacturing-facility-to-increase-availability-of-Fluzone-R-High-Dose-Quadrivalent-influenza-vaccine
SWIFTWATER, Pa., June 17, 2021 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) Center for Biologics Evaluation and Research has granted approval to Sanofi Pasteur, the vaccines global business unit of Sanofi, for an additional influenza manufacturing facility located in Swiftwater, PA. The newly completed facility further expands production and distribution of Sanofi's Fluzone
https://www.sanofi.com/en/canada
Sanofi has strong foundations in Canada going back over a century, and operates world-leading R&D and biomanufacturing facilities in Toronto. Sanofi also operates an artificial intelligence (AI) centre of excellence located in Toronto that uses leading technologies to develop world-class data and AI products that accelerate research and development.
https://www.news.sanofi.us/2022-06-07-Sanofi-unveils-new-900,000-square-foot-campus-at-Cambridge-Crossing
Sanofi at Cambridge Crossing consists of two buildings, both U.S. Green Building Council LEED ® Gold Certified, totaling 900,000 square feet and located at 450 Water Street and 350 Water Street. The campus incorporates state-of-the-art environmental features, including automated light dimming, CO 2 sensors, and advanced heating/cooling
https://www.fiercepharma.com/manufacturing/sanofi-opens-doors-canadas-largest-vaccine-plant-expects-2027-production-separate
On Thursday, Sanofi opened the doors to a new $800 million CAD ($586 million) state-of-the-art pediatric and adult vaccine plant on its Toronto campus. The 200,000 square-foot site will employ 200
https://www.sanofi.us/en/contact-us
Prescription Customer Care. For general information about our products and programs in the U.S., call 1-800-981-2491, fill out the form using the link below or check our Frequently Asked Questions. CONTACT CUSTOMER SERVICE.
https://www.sanofi.com/en/media-room/press-releases/2024/2024-05-31-05-05-00-2891263
Sanofi Forward-Looking Statements This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts. These statements include projections and estimates regarding the marketing and other potential of the
https://finance.yahoo.com/news/press-release-sanofi-completes-acquisition-130100242.html
Paris, May 30, 2024. Sanofi announced today the completion of its acquisition of Inhibrx, Inc. ("Inhibrx"). The acquisition adds SAR447537 (formerly INBRX-101) to Sanofi's rare disease
https://www.bloomberg.com/news/articles/2024-05-31/sanofi-s-chronic-lung-disease-drug-gets-eu-regulator-backing
May 31, 2024 at 12:11 AM PDT. Listen. 2:10. Sanofi 's Dupixent is close to being approved in Europe for use in helping patients with a chronic lung disorder, opening up another avenue of growth
https://www.reuters.com/business/healthcare-pharmaceuticals/fda-extends-deadline-requests-more-data-sanofis-dupixent-treating-smokers-lung-2024-05-31/
A logo on the Sanofi exhibition space at the Viva Technology conference dedicated to innovation and startups at Porte de Versailles exhibition center in Paris, France June 15, 2022.
https://www.globenewswire.com/news-release/2024/05/30/2890833/0/en/Press-Release-Sanofi-completes-acquisition-of-Inhibrx-Inc.html
Sanofi announced today the completion of its acquisition of Inhibrx, Inc. ("Inhibrx"). The acquisition adds SAR447537 (formerly INBRX-101) to Sanofi's rare disease pipeline, underscoring the
https://www.fiercebiotech.com/biotech/sanofi-institutes-global-restructure-layoffs-tow-after-full-pipeline-reprioritization-rd
Sanofi begins 'full pipeline reprioritization' with layoffs in tow, R&D chief tells staff. Five months after setting out a controversial new vision for the company, Sanofi's executives have begun
https://www.indeed.com/cmp/Sanofi/reviews?fcountry=US&floc=Knoxville%2C+TN
Reviews from Sanofi employees about Sanofi culture, salaries, benefits, work-life balance, management, job security, and more. Home. Company reviews. Find salaries. Upload your resume. Sign in. Sign in. Employers / Post Job. Start of main content. Sanofi. Happiness rating is 67 out of 100 67. 4.1 out
https://www.sanofi.us/en/our-company/governance/us-leadership
Head of Finance, Specialty Care & CFO North America. See more. Explore Sanofi's U.S. leadership in innovation and impact. Learn how our leaders drive forward-thinking strategies for a brighter future.
https://www.glassdoor.com/Reviews/Sanofi-Knoxville-Reviews-EI_IE9347.0,6_IL.7,16_IM455.htm
2 Sanofi reviews in Knoxville, TN. A free inside look at company reviews and salaries posted anonymously by employees.
https://www.sanofi.us/en/careers
Sanofi US is committed to providing access, equal opportunity and reasonable accommodation for individuals with disabilities in employment, its services, programs, and activities. Your recruiter can discuss potential reasonable accommodations that may be needed to participate in the job application or interview process, to perform essential job
https://www.linkedin.com/in/syndel-rasmussen-8460b194
Sanofi Consumer Healthcare North America recently received #BCorp certification, joining the movement alongside visionary companies working to… Liked by Syndel Rasmussen
https://www.sanofi.com/en/your-health/medicines
General Medicine Focus Areas. Cardiovascular Diseases. Diabetes. Continue to vaccines. Global pharmaceutical and healthcare company Sanofi's specialty care & general medicines focus areas.